A Phase 1, Open-label, Crossover Taste And Pharmacokinetic Study In Healthy Adult Volunteers To Evaluate The Palatability And Estimate The Bioavailability Of Three Prototype Formulations Of Crizotinib
Latest Information Update: 04 Jun 2014
At a glance
- Drugs Crizotinib (Primary)
- Indications Non-small cell lung cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors Pfizer
- 07 Apr 2014 According to the ClinicalTrials.gov record, status changed from recruiting to completed.
- 15 Dec 2013 New trial record